Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer (NCT03444844)
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer Patients With Intermediate/High Risk Primary Disease or Biochemical Recurrence After Treatment
🩺 Plain-English Summary (8th-Grade Level)
Initial performance of Ga-68-P16-093 in prostate cancer patients including dosimetry and preliminary efficacy evaluation in BCR patients, and correlation of Ga-68-P16-093 uptake with tissue histopathology in intermediate to high risk primary prostate cancer patients.
Who can join: Review the eligibility criteria below.
Location: Goodman Hall, Indiana Institute for Biomedical Imaging Sciences, Indiana University School of Medicine — Indianapolis, Indiana
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Goodman Hall, Indiana Institute for Biomedical Imaging Sciences, Indiana University School of Medicine — Indianapolis, Indiana
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Prostate Cancer Recurrent
- Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer — Toronto, Ontario
- Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer — Clearwater, Florida
- COAST Therapy in Advanced Solid Tumors and Prostate Cancer — Charleston, South Carolina
- Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era — Toronto, Ontario
Explore by condition: All Prostate Cancer Recurrent clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.